3.3 Contrast Timing, Reactions & Postprocedure Care
Key Takeaways
- Bolus tracking triggers the diagnostic scan automatically once a target vessel reaches a preset HU threshold (commonly ~100-150 HU above baseline); a timing bolus measures peak-enhancement time directly.
- Know the three-tier severity table: mild (hives/itching, monitor), moderate (bronchospasm/hypotension, immediate notification), severe (arrest/anaphylaxis, epinephrine + code).
- A vasovagal reaction is a hemodynamic/CNS response, not an allergic reaction, and is not treated with epinephrine.
- The classic premedication regimen for a documented prior reaction is oral steroid at 13, 7, and 1 hour before injection plus an antihistamine at 1 hour.
- For extravasation, stop the injection first, then assess, treat per protocol, and document volume/actions/notification - current guidance weighs signs/symptoms over a fixed volume cutoff.
Why Timing and Reaction Management Are High-Stakes Exam Content
The final three ARRT outline items in Contrast and Medication — scanning techniques, reactions, and postprocedure care — cover the moment contrast actually enters the patient's bloodstream and the minutes immediately after. Timing errors ruin a diagnostic study; reaction-management errors put a patient's life at risk. Both are exactly the kind of content ARRT tests with realistic, multi-step scenario questions rather than simple recall.
Scanning Techniques: Getting the Timing Right
CT enhancement is a moving target — attenuation in a given vessel or organ rises and falls within seconds — so three techniques exist to hit the right phase:
- Timing bolus (test bolus): a small contrast volume (commonly 15–20 mL) is injected while a series of very low-dose scans is repeated through one level of a target vessel. The rise and peak of attenuation on those repeated images tells the technologist exactly how many seconds after injection the vessel peaks, and that number becomes the scan delay for the full diagnostic bolus.
- Bolus tracking (vendor names vary — SmartPrep, SureStart, CARE Bolus): a region of interest is placed on a target vessel during the actual diagnostic injection, and the scanner monitors attenuation in real time. Once a preset Hounsfield unit (HU) threshold is reached (commonly on the order of 100–150 HU above the pre-contrast baseline), the system automatically triggers the diagnostic acquisition, sometimes after an additional short delay to allow the operator to instruct breath-holding.
- Scan delay: a fixed, empirically-set wait time used when a facility's protocol already has a well-established, reliable timing for that study, without a timing bolus or bolus tracking.
Typical Abdominal Enhancement Phases
| Phase | Approx. timing after injection start | Purpose |
|---|---|---|
| Arterial | ~25–35 seconds | Vascular anatomy, hypervascular lesions (e.g., HCC) |
| Portal venous | ~60–70 seconds | Routine abdominal soft-tissue enhancement |
| Delayed/excretory (nephrographic-urographic) | ~3–5+ minutes | Renal collecting system, delayed washout characterization |
Contrast Reactions
Reaction content is organized by the outline into recognition, allergy type, complications, and treatment — and a CT technologist's first job during any reaction is recognition and assessment: noticing the symptom, assessing severity, and knowing when to call a code, retrieve the crash cart, or begin CPR.
Allergy-Type Severity
| Severity | Typical signs | Immediate action |
|---|---|---|
| Mild | Hives/urticaria, itching, flushing, mild nausea | Monitor; reassurance; antihistamine if needed |
| Moderate | Bronchospasm/wheezing, facial or laryngeal edema, hypotension with tachycardia | Stop injection, notify radiologist immediately, prepare for medical intervention |
| Severe | Laryngeal edema with stridor, profound/unresponsive hypotension, cardiac or respiratory arrest | Call a code, begin ACLS/CPR as indicated, administer epinephrine |
Two other complication categories appear on the outline: nephrotoxicity (contrast-associated acute kidney injury, more likely in patients with reduced baseline eGFR, diabetes, or dehydration — see the pre-scan assessment content in Chapter 2 for eGFR thresholds) and physiological responses across airway, hemodynamic, and central nervous system categories (e.g., a vasovagal reaction is a CNS/hemodynamic response, not an allergic one, and is treated very differently — with position change and reassurance rather than epinephrine).
Treatment
- Types: corticosteroids (more effective as pre-treatment before a known-reactive patient's contrast than as acute rescue), antihistamines (e.g., diphenhydramine, for mild hives/itching), and epinephrine (first-line rescue medication for a severe anaphylactoid reaction, typically given intramuscularly in the anterolateral thigh).
- Indications and contraindications: epinephrine has relative cardiac cautions in some patients, but a life-threatening severe reaction is always treated with epinephrine regardless of those relative cautions — anaphylaxis outweighs the relative risk.
A common premedication protocol for a patient with a documented prior contrast reaction is oral corticosteroid (e.g., prednisone) at roughly 13, 7, and 1 hour before the contrast injection, plus an antihistamine about 1 hour before. A compressed alternative (e.g., methylprednisolone at 12 and 2 hours before) exists for patients who cannot complete the 13-hour lead time.
Postprocedure Care
- Extravasation/infiltration: contrast leaking from the vessel into surrounding soft tissue during power injection. Immediate technologist actions: stop the injection immediately, remove or reposition the IV per protocol, elevate the affected limb, apply a warm or cold compress per department protocol, and assess distal pulses/sensation. Current ACR guidance emphasizes evaluating signs and symptoms — severe pain, progressive swelling, skin blistering, or decreased capillary refill — rather than relying on a strict volume cutoff to decide on a surgical consult, although large estimated volumes (commonly cited around 100–150 mL) still warrant close monitoring and radiologist notification.
- Documentation: required elements include the estimated extravasation volume, the actions taken, patient response, and physician notification — mirroring the same documentation discipline required at venipuncture.
Exam Scenario
Ninety seconds into a power injection for a chest CTA, the patient reports burning pain and the technologist observes localized swelling at the IV site with no swelling elsewhere. The correct first action is to stop the injector immediately, not to wait for the scan to finish or to reduce the flow rate. After stopping, the technologist assesses the limb, applies a compress per protocol, documents the estimated volume and findings, and notifies the radiologist.
Key Takeaways
- Bolus tracking triggers the diagnostic scan automatically once a target vessel reaches a preset HU threshold (commonly ~100–150 HU above baseline); a timing bolus measures peak-enhancement time directly using a small test injection.
- Know the three-tier severity table: mild (hives/itching, monitor), moderate (bronchospasm/hypotension, immediate notification), severe (arrest/anaphylaxis, epinephrine + code).
- A vasovagal reaction is a hemodynamic/CNS response, not an allergic reaction, and is not treated with epinephrine.
- The classic premedication regimen for a documented prior reaction is oral steroid at 13, 7, and 1 hour before injection plus an antihistamine at 1 hour.
- For extravasation, stop the injection first, then assess, treat per protocol, and document volume/actions/notification — current guidance weighs symptoms over a fixed volume cutoff.
During a power injection, a patient develops facial swelling, audible wheezing, and a blood pressure drop with a rising heart rate. How should this reaction be classified, and what is the immediate technologist action?
What is the primary purpose of bolus tracking during a CT angiography study?
A technologist notices contrast extravasation at the IV site partway through a power injection. What is the correct first action?